On the call is Stefano Caroti, President and Chief Executive Officer and Steven J. Fasching, Chief Financial Officer. Deep consumer connections, meaningful runways for growth and expansion across head to toe categories channels and regions.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Deckers Outdoor (NYSE:DECK) reported record fiscal 2026 revenue and earnings as growth at HOKA and UGG continued to offset a more volatile macroeconomic backdrop, with management outlining plans for high single-digit annual revenue growth through fiscal 2030. On the company’s fourth-quarter earning
For the fiscal fourth quarter ended March 31, Deckers reported a record $1.12 billion in sales, up 10%.
The footwear and apparel company posted a profit of $135.6 million, boosted by momentum across its Hoka brand and enduring demand for Ugg.
Footwear and apparel conglomerate Deckers (NYSE:DECK) will be announcing earnings results this Thursday afternoon. Here’s what you need to know.
Investing.com -- Piper Sandler upgraded Deckers Outdoor Corporation to “Neutral” from “Underweight,” saying the recent pullback in the stock has created a more balanced risk-reward profile ahead of the company’s fiscal fourth-quarter earnings report on May 21.
a.k.a. Brands (AKA) delivered earnings and revenue surprises of +32.31% and +0.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Shares of Under Armour plummeted Tuesday after the sportswear retailer finished off a third consecutive fiscal year of falling sales and issued weak guidance for 2027. The company reported an adjusted loss of 3 cents a share for the fiscal fourth quarter, a tick below analysts’ consensus call for a loss of 2 cents. Analysts had expected slight revenue growth and adjusted earnings of 23 cents a share.
Investing.com -- Wells Fargo on Friday reshuffled its ratings across the U.S. apparel and retail sector, upgrading Victoria’s Secret and downgrading Nike and Deckers, arguing that the rapid adoption of GLP-1 weight-loss drugs is impacting consumer spending in ways that favor clothing over footwear and athletic wear.